Viewing Study NCT02004392


Ignite Creation Date: 2025-12-24 @ 3:26 PM
Ignite Modification Date: 2026-02-25 @ 4:49 PM
Study NCT ID: NCT02004392
Status: TERMINATED
Last Update Posted: 2016-05-03
First Post: 2013-11-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Sponsor: FORUM Pharmaceuticals Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
None Dementia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alzheimer's disease View
None Cognition View
None Alpha-7 nAChR View